new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing

November 2000

Merck will soon market new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing.

The new tabs come in two strengths...35 and 70 mg.

The 35 mg tab is for patients on 5 mg/d to PREVENT osteoporosis.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Many patients with renal insufficiency SHOULD be getting an ACE inhibitor
Infectious Diseases treat cold sores with a new OTC cream called Abreva (docosanol)
Infectious Diseases there WILL be enough flu vaccine to go around this season
Diabetes Glucophage XR, a new extended-release metformin tablet for once-a-day dosing
Osteoporosis new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing
Osteoporosis treating osteoporosis in MEN
Osteoporosis Lead contamination in calcium supplements
OTC Products ban the use of phenylpropanolamine in OTC products
OTC Products Colace liquid (docusate sodium) works better than Cerumenex to loosen ear wax
OTC Products Mercury thermometers will soon be a thing of the past
Qvar beclomethasone inhaler for asthma
inhaled steroids DON'T affect LONG-TERM growth in children
Cardiology More patients are now candidates for ACE inhibitors
Cardiology Lescol XL 80 mg, a new higher-strength fluvastatin tablet
Hematology & Oncology new herbal product for prostate cancer called PC-SPES (pea-see spehz)
Pregnancy which psychotropics to give women during pregnancy
Women's Health Lunelle, a new INJECTABLE contraceptive
OTC Products Pepcid Complete, the first H2-blocker and antacid COMBO for heartburn